EASTMAN CHEMICAL CO (EMN) Fundamental Analysis & Valuation

NYSE:EMN • US2774321002

Current stock price

72.55 USD
+1.35 (+1.9%)
At close:
72.56 USD
+0.01 (+0.01%)
After Hours:

This EMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. EMN Profitability Analysis

1.1 Basic Checks

  • In the past year EMN was profitable.
  • In the past year EMN had a positive cash flow from operations.
  • EMN had positive earnings in each of the past 5 years.
  • In the past 5 years EMN always reported a positive cash flow from operatings.
EMN Yearly Net Income VS EBIT VS OCF VS FCFEMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • EMN has a better Return On Assets (3.19%) than 73.49% of its industry peers.
  • EMN has a Return On Equity of 7.95%. This is in the better half of the industry: EMN outperforms 75.90% of its industry peers.
  • EMN has a better Return On Invested Capital (6.13%) than 67.47% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EMN is in line with the industry average of 6.58%.
Industry RankSector Rank
ROA 3.19%
ROE 7.95%
ROIC 6.13%
ROA(3y)5.08%
ROA(5y)5.24%
ROE(3y)13.33%
ROE(5y)14.08%
ROIC(3y)7.13%
ROIC(5y)8.47%
EMN Yearly ROA, ROE, ROICEMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • The Profit Margin of EMN (5.42%) is better than 73.49% of its industry peers.
  • EMN's Profit Margin has been stable in the last couple of years.
  • EMN has a Operating Margin (10.56%) which is in line with its industry peers.
  • EMN's Operating Margin has declined in the last couple of years.
  • EMN has a Gross Margin of 21.09%. This is in the lower half of the industry: EMN underperforms 60.24% of its industry peers.
  • EMN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.56%
PM (TTM) 5.42%
GM 21.09%
OM growth 3Y-5.12%
OM growth 5Y-2.29%
PM growth 3Y-10.27%
PM growth 5Y-0.81%
GM growth 3Y1.45%
GM growth 5Y-1.98%
EMN Yearly Profit, Operating, Gross MarginsEMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

4

2. EMN Health Analysis

2.1 Basic Checks

  • EMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, EMN has less shares outstanding
  • The number of shares outstanding for EMN has been reduced compared to 5 years ago.
  • The debt/assets ratio for EMN has been reduced compared to a year ago.
EMN Yearly Shares OutstandingEMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
EMN Yearly Total Debt VS Total AssetsEMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.37 indicates that EMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.37, EMN is in the better half of the industry, outperforming 62.65% of the companies in the same industry.
  • EMN has a debt to FCF ratio of 11.29. This is a negative value and a sign of low solvency as EMN would need 11.29 years to pay back of all of its debts.
  • EMN has a Debt to FCF ratio (11.29) which is in line with its industry peers.
  • EMN has a Debt/Equity ratio of 0.70. This is a neutral value indicating EMN is somewhat dependend on debt financing.
  • EMN's Debt to Equity ratio of 0.70 is in line compared to the rest of the industry. EMN outperforms 48.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 11.29
Altman-Z 2.37
ROIC/WACC0.54
WACC11.4%
EMN Yearly LT Debt VS Equity VS FCFEMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • EMN has a Current Ratio of 1.37. This is a normal value and indicates that EMN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of EMN (1.37) is worse than 73.49% of its industry peers.
  • EMN has a Quick Ratio of 1.37. This is a bad value and indicates that EMN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EMN has a worse Quick ratio (0.63) than 89.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.63
EMN Yearly Current Assets VS Current LiabilitesEMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

4

3. EMN Growth Analysis

3.1 Past

  • The earnings per share for EMN have decreased strongly by -31.56% in the last year.
  • EMN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.54% yearly.
  • Looking at the last year, EMN shows a decrease in Revenue. The Revenue has decreased by -6.71% in the last year.
  • Measured over the past years, EMN shows a small growth in Revenue. The Revenue has been growing by 0.65% on average per year.
EPS 1Y (TTM)-31.56%
EPS 3Y-11.65%
EPS 5Y-2.54%
EPS Q2Q%-59.89%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y-6.13%
Revenue growth 5Y0.65%
Sales Q2Q%-12.12%

3.2 Future

  • Based on estimates for the next years, EMN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.84% on average per year.
  • EMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.77% yearly.
EPS Next Y9.23%
EPS Next 2Y12.21%
EPS Next 3Y12.72%
EPS Next 5Y14.84%
Revenue Next Year0.44%
Revenue Next 2Y1.9%
Revenue Next 3Y2.39%
Revenue Next 5Y1.77%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EMN Yearly Revenue VS EstimatesEMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
EMN Yearly EPS VS EstimatesEMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

5

4. EMN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.44, which indicates a correct valuation of EMN.
  • Based on the Price/Earnings ratio, EMN is valued cheaper than 84.34% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of EMN to the average of the S&P500 Index (24.75), we can say EMN is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 12.30, which indicates a correct valuation of EMN.
  • 80.72% of the companies in the same industry are more expensive than EMN, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.10. EMN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.44
Fwd PE 12.3
EMN Price Earnings VS Forward Price EarningsEMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EMN is valued a bit cheaper than 77.11% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMN indicates a somewhat cheap valuation: EMN is cheaper than 73.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.52
EV/EBITDA 8.59
EMN Per share dataEMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • EMN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as EMN's earnings are expected to grow with 12.72% in the coming years.
PEG (NY)1.46
PEG (5Y)N/A
EPS Next 2Y12.21%
EPS Next 3Y12.72%

8

5. EMN Dividend Analysis

5.1 Amount

  • EMN has a Yearly Dividend Yield of 4.63%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.04, EMN pays a better dividend. On top of this EMN pays more dividend than 91.57% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, EMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.63%

5.2 History

  • The dividend of EMN has a limited annual growth rate of 4.78%.
  • EMN has paid a dividend for at least 10 years, which is a reliable track record.
  • EMN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.78%
Div Incr Years15
Div Non Decr Years30
EMN Yearly Dividends per shareEMN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • EMN pays out 80.38% of its income as dividend. This is not a sustainable payout ratio.
  • EMN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP80.38%
EPS Next 2Y12.21%
EPS Next 3Y12.72%
EMN Yearly Income VS Free CF VS DividendEMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
EMN Dividend Payout.EMN Dividend Payout, showing the Payout Ratio.EMN Dividend Payout.PayoutRetained Earnings

EMN Fundamentals: All Metrics, Ratios and Statistics

EASTMAN CHEMICAL CO

NYSE:EMN (3/30/2026, 8:04:00 PM)

After market: 72.56 +0.01 (+0.01%)

72.55

+1.35 (+1.9%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners91.54%
Inst Owner Change-4.65%
Ins Owners0.84%
Ins Owner Change7.23%
Market Cap8.28B
Revenue(TTM)8.75B
Net Income(TTM)474.00M
Analysts76.36
Price Target78.6 (8.34%)
Short Float %4.56%
Short Ratio2.94
Dividend
Industry RankSector Rank
Dividend Yield 4.63%
Yearly Dividend3.33
Dividend Growth(5Y)4.78%
DP80.38%
Div Incr Years15
Div Non Decr Years30
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.02%
Min EPS beat(2)-3.04%
Max EPS beat(2)3.07%
EPS beat(4)1
Avg EPS beat(4)-2.08%
Min EPS beat(4)-8.32%
Max EPS beat(4)3.07%
EPS beat(8)5
Avg EPS beat(8)3.91%
EPS beat(12)9
Avg EPS beat(12)5.28%
EPS beat(16)11
Avg EPS beat(16)2.19%
Revenue beat(2)0
Avg Revenue beat(2)-3.37%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)-3.24%
Revenue beat(4)0
Avg Revenue beat(4)-2.73%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)-1.63%
Revenue beat(8)1
Avg Revenue beat(8)-1.44%
Revenue beat(12)1
Avg Revenue beat(12)-2.45%
Revenue beat(16)3
Avg Revenue beat(16)-1.36%
PT rev (1m)1.31%
PT rev (3m)5.1%
EPS NQ rev (1m)-0.65%
EPS NQ rev (3m)-11.52%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)-5.49%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE 13.44
Fwd PE 12.3
P/S 0.95
P/FCF 19.52
P/OCF 8.53
P/B 1.39
P/tB 6.24
EV/EBITDA 8.59
EPS(TTM)5.4
EY7.44%
EPS(NY)5.9
Fwd EY8.13%
FCF(TTM)3.72
FCFY5.12%
OCF(TTM)8.5
OCFY11.72%
SpS76.7
BVpS52.24
TBVpS11.62
PEG (NY)1.46
PEG (5Y)N/A
Graham Number79.67
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 7.95%
ROCE 7.57%
ROIC 6.13%
ROICexc 6.43%
ROICexgc 10.69%
OM 10.56%
PM (TTM) 5.42%
GM 21.09%
FCFM 4.84%
ROA(3y)5.08%
ROA(5y)5.24%
ROE(3y)13.33%
ROE(5y)14.08%
ROIC(3y)7.13%
ROIC(5y)8.47%
ROICexc(3y)7.54%
ROICexc(5y)8.89%
ROICexgc(3y)12.66%
ROICexgc(5y)15.23%
ROCE(3y)8.8%
ROCE(5y)10.46%
ROICexgc growth 3Y-15.19%
ROICexgc growth 5Y-0.92%
ROICexc growth 3Y-12.8%
ROICexc growth 5Y1.35%
OM growth 3Y-5.12%
OM growth 5Y-2.29%
PM growth 3Y-10.27%
PM growth 5Y-0.81%
GM growth 3Y1.45%
GM growth 5Y-1.98%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 11.29
Debt/EBITDA 2.92
Cap/Depr 106.43%
Cap/Sales 6.24%
Interest Coverage 4.3
Cash Conversion 67.5%
Profit Quality 89.45%
Current Ratio 1.37
Quick Ratio 0.63
Altman-Z 2.37
F-Score5
WACC11.4%
ROIC/WACC0.54
Cap/Depr(3y)130.13%
Cap/Depr(5y)124.87%
Cap/Sales(3y)7.2%
Cap/Sales(5y)6.56%
Profit Quality(3y)75.52%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)-31.56%
EPS 3Y-11.65%
EPS 5Y-2.54%
EPS Q2Q%-59.89%
EPS Next Y9.23%
EPS Next 2Y12.21%
EPS Next 3Y12.72%
EPS Next 5Y14.84%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y-6.13%
Revenue growth 5Y0.65%
Sales Q2Q%-12.12%
Revenue Next Year0.44%
Revenue Next 2Y1.9%
Revenue Next 3Y2.39%
Revenue Next 5Y1.77%
EBIT growth 1Y-31.04%
EBIT growth 3Y-10.93%
EBIT growth 5Y-1.66%
EBIT Next Year59.9%
EBIT Next 3Y23.02%
EBIT Next 5Y20.52%
FCF growth 1Y-38.37%
FCF growth 3Y6.5%
FCF growth 5Y-16.93%
OCF growth 1Y-24.63%
OCF growth 3Y-0.17%
OCF growth 5Y-7.79%

EASTMAN CHEMICAL CO / EMN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EASTMAN CHEMICAL CO?

ChartMill assigns a fundamental rating of 5 / 10 to EMN.


Can you provide the valuation status for EASTMAN CHEMICAL CO?

ChartMill assigns a valuation rating of 5 / 10 to EASTMAN CHEMICAL CO (EMN). This can be considered as Fairly Valued.


Can you provide the profitability details for EASTMAN CHEMICAL CO?

EASTMAN CHEMICAL CO (EMN) has a profitability rating of 5 / 10.


What is the expected EPS growth for EASTMAN CHEMICAL CO (EMN) stock?

The Earnings per Share (EPS) of EASTMAN CHEMICAL CO (EMN) is expected to grow by 9.23% in the next year.


How sustainable is the dividend of EASTMAN CHEMICAL CO (EMN) stock?

The dividend rating of EASTMAN CHEMICAL CO (EMN) is 8 / 10 and the dividend payout ratio is 80.38%.